Assignee
ZENTARIS GMBH
DE·19 granted patents·7 pending applications·293 citations·filing 1995–2009
Top patents by PatentIndex Score
26 records- 0195US7026310B2Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2005·Granted Apr 11, 2006·39 cites·14 claims
- 0292US7056912B2Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2003·Granted Jun 6, 2006·41 cites·15 claims
- 0392US6936615B2Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2003·Granted Aug 30, 2005·38 cites·14 claims
- 0492US6855723B2Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compoundsZENTARIS GMBH·Filed 2002·Granted Feb 15, 2005·53 cites·3 claims
- 0588US7214662B2Injectable solution of an LHRH antagonistZENTARIS GMBH·Filed 2002·Granted May 8, 2007·33 cites·10 claims
- 0686US7871977B2Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicamentsZENTARIS GMBH·Filed 2005·Granted Jan 18, 2011·9 cites·22 claims
- 0784US7829724B2Triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptorsZENTARIS GMBH·Filed 2006·Granted Nov 9, 2010·14 cites·4 claims
- 0879US6867191B2Preparation and use of oligopeptide lyophilisate for gonad protectionZENTARIS GMBH·Filed 2002·Granted Mar 15, 2005·6 cites·2 claims
- 0977US6903080B2Disease treatment with novel phospholipid derivativesZENTARIS GMBH·Filed 2002·Granted Jun 7, 2005·9 cites·3 claims
- 1075US7211588B2N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparationZENTARIS GMBH·Filed 2004·Granted May 1, 2007·7 cites·12 claims
- 1175US7205299B2Indole derivatives having an apoptosis-inducing effectZENTARIS GMBH·Filed 2004·Granted Apr 17, 2007·7 cites·21 claims
- 1275US7005418B1Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstructionZENTARIS GMBH·Filed 2000·Granted Feb 28, 2006·7 cites·17 claims
- 1371US7884071B2Administration form for pharmaceutically active peptides with sustained release and method for the production thereofZENTARIS GMBH·Filed 2003·Granted Feb 8, 2011·8 cites·33 claims
- 1466US7148195B2LHRH antagonists having improved solubility propertiesZENTARIS GMBH·Filed 2003·Granted Dec 12, 2006·2 cites·4 claims
- 1566US7087214B2Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseasesZENTARIS GMBH·Filed 2003·Granted Aug 8, 2006·6 cites·22 claims
- 1666US6780972B2Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide saltsZENTARIS GMBH·Filed 2001·Granted Aug 24, 2004·6 cites·5 claims
- 1759US7906479B2Sterile suspensions of slightly soluble basic peptide complexes and pharmaceutical formulations containing themZENTARIS GMBH·Filed 2008·Granted Mar 15, 2011·0 cites·9 claims
- 1858US7732412B2Methods of treatment using novel LHRH antagonists having improved solubility propertiesZENTARIS GMBH·Filed 2006·Granted Jun 8, 2010·0 cites·8 claims
- 1958US2005245523A1Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2005·Application pending·0 cites
- 2057US2008113991A1Pyridopyrazines and the use thereof as kinase inhibitorsZENTARIS GMBH·Filed 2007·Application pending·0 cites
- 2153US2006240038A1Cells used as carriers for bacteriaZENTARIS GMBH·Filed 2004·Application pending·0 cites
- 2250US6828415B2Oligopeptide lyophilisate, their preparation and useZENTARIS GMBH·Filed 1995·Granted Dec 7, 2004·8 cites·4 claims
- 2346US2009208461A1Recombinant bacteria with e.coli hemolysin secretion system and increased expression and/or secretion of hlya, process of manufacturing and uses thereofZENTARIS GMBH·Filed 2009·Application pending·0 cites
- 2444US2005267303A1Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticalsZENTARIS GMBH·Filed 2005·Application pending·0 cites
- 2541US2007167408A1Novel alkyl phospholipid derivatives with reduced cytotoxicity and uses thereofZENTARIS GMBH·Filed 2006·Application pending·0 cites
- 2640US2007010548A1Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereofZENTARIS GMBH·Filed 2004·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →